Thermo Fisher Scientific Extends PCT Assay Licensing Agreement with Wako Pure Chemical Industries, Ltd.

Combination of Thermo Scientific B•R•A•H•M•S PCT Assay and SphereLight™ and µTASWako™ i30 Systems Used to Test Patients Suspected of Having Sepsis

Thermo Fisher Scientific PCT Assay for Sepsis Available for Abbott Analyzers More Patients will Benefit from Earlier Detection

WALTHAM, Mass., (January 30, 2012) – Thermo Fisher Scientific, the world leader in serving science, today announced an agreement with global healthcare provider Abbott Laboratories to make its Procalcitonin (PCT) assay available with Abbott’s immunochemistry analyzers.

Prof. Kypros Nicolaides Visits Thermo Fisher Scientific in Hennigsdorf

Prof. Kypros Nicolaides, director of the Fetal Medicine Centre and founder of the Fetal Medicine Foundation (FMF, London), visited the Thermo Scientific Biomarkers site in Hennigsdorf (near Berlin) on 1 December 2011.

Thermo Scientific Biomarkers Thyroid Forum successfully ended The 2nd International Workshop on Graves' Orbitopathy

The Thermo Scientific Biomarkers Thyroid Forum was held in Berlin on 5 November 2011. The event was supported by the European Group on Graves' Orbitopathy (EUGOGO). A total of 90 participants from eight European countries met in Berlin for an interdisciplinary exchange. They included internists, endocrinologists, ophthalmologists and laboratory doctors.

Software-Update: Thermo Scientific B·R·A·H·M·S Fast Screen pre I plus V 1.3 for all KRYPTOR systems

Thermo Scientific Biomarkers has brought an Update of the CE marked prenatal screening software B·R·A·H·M·S Fast Screen pre I plus onto the market. The new version 1.3 of the prenatal screening software is available as of November 2011 - currently deliverable in the following languages: German, English and French.

Thermo Scientific Biomarkers launches new assay: Thermo Scientific B·R·A·H·M·S TRAK human KRYPTOR

Thermo Scientific Biomarkers launched the automated TRAK human KRYPTOR assay in countries that accept CE certification. This assay is highly specific for the autoimmune disorder Graves´ disease.

B·R·A·H·M·S-Forum: Workshop on thyroid cancer big success

Hennigsdorf / Berlin 24.11.2009. At the invitation of B·R·A·H·M·S over 50 medics and scientists made their way to Berlin on November 6 and 7 to get an update on most recent developments in the field of thyroid cancer.

L’autorità garante della concorrenza permette l’acquisizione di B·R·A·H·M·S da parte di Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) ha acquisito tutte le quote di B·R·A·H·M·S Holding GmbH. L’accordo contrattuale è stato reso noto all’inizio di settembre. Ora, dopo un esame durato quattro settimane, le autorità di vigilanza competenti hanno espresso la loro approvazione.

The struggle against bacterial resistance and increasing medical costs:

ProHOSP study demonstrates the value of Procalcitonin marker for lower respiratory tract infections

B·R·A·H·M·S e Thermo Fisher Scientific uniscono le proprie forze creando un centro leader nella diagnostica specializzata.

B·R·A·H·M·S annuncia la sottoscrizione di uno Share Purchase Agreement (SPA) con Thermo Fisher Scientific Inc. (NYSE: TMO) per l’acquisizione del 100% del capitale azionario di B·R·A·H·M·S Holding GmbH, equivalente a EUR 330 milioni (circa USD 470 milioni) inclusi debiti e altre passività. Il perfezionamento della transazione, soggetta all’approvazione delle autorità competenti, è previsto per la fine di settembre 2009.